Drug Discovery Informatics Market To Reach $7.03 Billion By 2030

Drug Discovery Informatics Market Growth & Trends

The global drug discovery informatics market size is anticipated to reach USD 7.03 billion by 2030, growing at a CAGR of 11.6% from 2025 to 2030, as per a new study by Grand View Research, Inc. Implementation of drug discovery software for deriving market insights due to various benefits, including fast drug design & synthesis, effective monitoring of disease progression, and data integrity management, has picked up considerably among the researchers during the recent past, fueling the industry growth.

The increasing need for new molecules is propelling the use of informatics solutions aimed at accelerating the whole drug discovery process by discovering rational drug molecules through the target macromolecule interaction. Market players are being funded to expand their drug discovery platforms, further supporting the market growth. For example, in September 2020, Ardigen entered into a partnership with the National Centre for Research and Development to obtain its financing for the creation of new technology.

This technology is meant to disrupt the process of creating T-cells receptors-based treatments for immuno-oncology. Previously, Ardigen developed a platform for predicting neoantigens known as, ArdImmune Vax that employs ready-to-use Artificial Intelligence (AI) and bioinformatics tools for predicting best sets of neoantigens as immunological targets of adoptive cell therapies and vaccines for cancer. Further, chemical informatics tools have become immensely popular in recent times, specifically with regard to solving the necessities with the recently Covid-19 pandemic.

For example, an experiment conducted in January 2021 demonstrated the use of chemical digital solutions for speeding up SARS-CoV-2 Mpro inhibitor searches through data analysis of past activity data of SARS-CoV main protease (Mpro) inhibitors. Furthermore, QSAR models aided in data mining of molecules towards quick Covid-19 drug discovery. Therefore, the necessity for enabling drug development for Covid-19 is bound to drive industry growth in the next few years.

Drug Discovery Informatics Market Report Highlights

• The sequence analysis platforms led the market and held the highest revenue share of 36.4% in 2024. The bioinformatics solutions are extensively used for the creation of primary and secondary databases of nucleic acid, proteins, and other biomolecule sequences.
• The discovery informatics segment held the highest revenue share of approximately 60.2% in 2024, with a strong emphasis on creating precision medicines. Precision medicine is all about delivering customized medical treatment based on a person's genetic and molecular makeup.
• Pharmaceutical and biotech firms were the market leaders, with the highest revenue share of 48.4% in 2024. This is driven by higher R&D investments, especially in precision medicine.
• North America was the leading region in the global market in 2024 because of the presence of major market players and well-established R&D facilities in the country